atai Life Sciences (NASDAQ:ATAI, ETR:9VC) is gaining momentum in the psychedelics space, with Jefferies analysts highlighting the company’s potential to leapfrog rival GH Research (NASDAQ:GHRS) and establish a leading position in the treatment-resistant depression (TRD) market with its intranasal 5-MeO-DMT candidate BPL-003.
The analysts maintain a ‘Buy’ rating and $7 price target on atai, about double the stock’s price at the time of writing.
Shares of Thermo Fisher Scientific Inc (NYSE:TMO, ETR:TN8) jumped nearly 12% on Wednesday morning after the company reported second-quarter results that topped Wall Street estimates, fueled by strong demand across its life sciences and diagnostics segments.
The company posted revenue of $10.86 billion, surpassing analysts’ expectations of $10.69 billion and marking a 3% year-over-year increase.
GE Vernova (NYSE:GEV) shares surged almost 15% after the energy company’s second quarter earnings beat expectations, driven by strong performance in its Power and Electrification segments.
Earnings per share (EPS) of $1.86 were significantly ahead of estimates of $1.50.
A new wave of 'meme stocks' has apparently emerged, though some analysts said this was a product of summer stock market madness.
Retail-driven speculation has pushed shares of Opendoor Technologies Inc (NASDAQ:OPEN), Kohl's Corporation (NYSE:KSS), Krispy Kreme Doughnuts Inc (NASDAQ:DNUT) and GoPro Inc (NASDAQ:GPRO) higher, despite a near-total absence of corporate news.
Texas Instruments Inc (NASDAQ:TXN) shares plunged 12% as the semiconductor company issued a soft outlook for the third quarter, which overshadowed strong results for Q2.
The company guided Q3 revenue between $4.45 billion and $4.8 billion, compared to Street estimates of $4.59 billion.
Standard Uranium Ltd (TSX-V:STND, OTCQB:STTDF) has reported positive results from a high-resolution airborne Time Domain Electromagnetic (TDEM) survey completed at its Corvo uranium project in northern Saskatchewan, Canada.
The survey confirmed and refined previously identified conductive corridors, outlining 29 kilometres of prospective conductor strike length and defining multiple high-priority target areas for follow-up exploration.
Hochschild Mining PLC's (LSE:HOC, OTCQX:HCHDF) shares climbed 8% following a robust first-half operational update, driven by solid performances at its Inmaculada and San Jose mines.
The company reported attributable production of 161,600 gold equivalent ounces and 13.4 million silver equivalent ounces in the first half.
Caledonia Mining Corporation PLC's (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) shares rose 9% after the gold miner signalled a profit for the second quarter, with performance described as materially better than expected.
This follows a strong first-quarter result, underpinned by robust production and sustained gold prices.
Gem Diamonds Limited (LSE:GEMD, OTC:GMDMF) shares fell 15% following a challenging first-half trading update and the announcement of cost-cutting measures.
The company reported a 43% decline in revenue to $44.7 million, with carats sold down 22% to 44,360 and the average price per carat falling 26% to $1,008.
Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) saw its share price rise 21% following a strong second-quarter trading update.
The company reported that net revenues from its iron deficiency treatment, ACCRUFeR, doubled to $12.8 million, up from $6.4 million in Q1.
Itaconix PLC (AIM:ITX, OTCQB:ITXXF) shares rose 9% following the announcement of record first-half revenue growth.
The plant-based polymer specialist reported a 73% increase in revenue to $4.8 million compared with the same period last year, surpassing market expectations. This also marks a 30% rise on the second half of 2024.